An interventional study of RISE for Nurse Preceptors Program in Mental Health, Resilience and Self-Compassion, sponsored by AdventHealth. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by AdventHealth · Not applicable, Interventional, and Supportive care
The purpose of this study is to determine whether RISE for Nurse Preceptors has a significant impact on nurse preceptors' burnout, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.
154 studies on the registry are indexed under Empowerment; 31 are open to participants now.
This study's planned enrollment of 124 is below the median of 141 across 132 interventional studies indexed under Empowerment.
Browse Empowerment studies →AdventHealth is the lead sponsor of 113 studies on the registry; 22 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.
Compared within Empowerment, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group will attend the RISE for Nurse Preceptors program, which consists of nine 90-minute weekly psychoeducational group sessions facilitated by a licensed mental health counselor (LMHC)
Behavioral: RISE for Nurse Preceptors Program
Control group will attend the RISE for Nurse Preceptors program after the 6-month wait-list period
Behavioral: RISE for Nurse Preceptors Program
Psychoeducational group program designed to impact resilience, insight, self-compassion, and empowerment
Professional Quality of Life Scale
30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Posttraumatic Growth Inventory
21-item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Brief Resilience Scale
6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Self-Reflection and Insight Scale
20-item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Self-Compassion Scale - Short Form
12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Psychological Empowerment Instrument
12-item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
General Self-Efficacy Scale
10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Perceived Stress Scale
10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Moral Injury Outcomes Scale
14-item questionnaire with the following response categories: 0=strongly agree, 1=disagree, 2=neither agree or disagree, 3=agree, 4=strongly agree
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Brief COPE
28-item questionnaire with a scale of 1-4, with 1 meaning I haven't been doing this at all; and 4 meaning I've been doing this a lot
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Generalized Anxiety Disorder - 2 item scale
2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Patient Health Questionnaire - 2 item
2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Preceptor Self-Assessment Tool
40-item scale with the following response categories: 1 (lowest), 2 (low), 3 (average), 4 (high), 5 (highest).
Time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.